open access

Vol 14, No 2 (2020)
Case report
Published online: 2020-05-29
Get Citation

Methadone in the treatment of bone pain in a patient with disseminated breast cancer

Krzysztof Nosek, Wojciech Leppert, Łukasz Puchała, Aleksandra Pawlos, Dariusz Onichimowski
DOI: 10.5603/PMPI.2020.0017
·
Palliat Med Pract 2020;14(2):115-119.

open access

Vol 14, No 2 (2020)
Case report
Published online: 2020-05-29

Abstract

Treatment of pain is an important element of therapeutic management in cancer patients. The article presents
the case of a patient diagnosed with breast cancer, which spread to the liver and lungs and presenting
with severe bone pain syndrome caused by lumbosacral metastases. Treatment of pain with non-opioid
analgesics, opioids, analgesic adjuvants and palliative radiotherapy proved ineffective. The addition of
small doses of methadone to the applied pharmacotherapy produced a satisfactory analgesic effect and a
significant functional improvement (an ability to move around without increased pain) as well as ensured
a better quality of patient’s life.

Abstract

Treatment of pain is an important element of therapeutic management in cancer patients. The article presents
the case of a patient diagnosed with breast cancer, which spread to the liver and lungs and presenting
with severe bone pain syndrome caused by lumbosacral metastases. Treatment of pain with non-opioid
analgesics, opioids, analgesic adjuvants and palliative radiotherapy proved ineffective. The addition of
small doses of methadone to the applied pharmacotherapy produced a satisfactory analgesic effect and a
significant functional improvement (an ability to move around without increased pain) as well as ensured
a better quality of patient’s life.

Get Citation

Keywords

adverse effects, methadone, opioid analgesics, pain, quality of life, treatment

About this article
Title

Methadone in the treatment of bone pain in a patient with disseminated breast cancer

Journal

Palliative Medicine in Practice

Issue

Vol 14, No 2 (2020)

Pages

115-119

Published online

2020-05-29

DOI

10.5603/PMPI.2020.0017

Bibliographic record

Palliat Med Pract 2020;14(2):115-119.

Keywords

adverse effects
methadone
opioid analgesics
pain
quality of life
treatment

Authors

Krzysztof Nosek
Wojciech Leppert
Łukasz Puchała
Aleksandra Pawlos
Dariusz Onichimowski

References (24)
  1. Mercadante S, Bruera E. Opioid switching in cancer pain: From the beginning to nowadays. Crit Rev Oncol Hematol. 2016; 99: 241–248.
  2. Fallon M, Giusti R, Aielli F, et al. ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org, ESMO Guidelines Committee. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018; 29(Suppl 4): iv166–iv191.
  3. Porta-Sales J, Garzón-Rodríguez C, Villavicencio-Chávez C, et al. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study. Oncologist. 2016; 21(8): 981–987.
  4. Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. The Lancet Oncology. 2012; 13(2): e58–e68.
  5. Bolan E, Tallarida R, Pasternak G. Synergy between μ Opioid Ligands: Evidence for Functional Interactions among μ Opioid Receptor Subtypes. Journal of Pharmacology and Experimental Therapeutics. 2002; 303(2): 557–562.
  6. Fürst P, Lundström S, Klepstad P, et al. The Use of Low-Dose Methadone as Add-On to Regular Opioid Therapy in Cancer-Related Pain at End of Life: A National Swedish Survey in Specialized Palliative Care. J Palliat Med. 2020; 23(2): 226–232.
  7. Fürst P, Lundström S, Klepstad P, et al. Improved Pain Control in Terminally Ill Cancer Patients by Introducing Low-Dose Oral Methadone in Addition to Ongoing Opioid Treatment. J Palliat Med. 2018; 21(2): 177–181.
  8. Courtemanche F, Dao D, Gagné F, et al. Methadone as a Coanalgesic for Palliative Care Cancer Patients. J Palliat Med. 2016; 19(9): 972–978.
  9. Mercadante S. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Pain Med. 2012; 13(3): 399–404.
  10. Palat G, Chary S. Practical Guide for Using Methadone in Pain and Palliative Care Practice. Indian J Palliat Care. 2018; 24(Suppl 1): S21–S29.
  11. Mercadante S, Bruera E. Methadone as a First-Line Opioid in Cancer Pain Management: A Systematic Review. J Pain Symptom Manage. 2018; 55(3): 998–1003.
  12. Sunilkumar MM, Lockman K. Practical Pharmacology of Methadone: A Long-acting Opioid. Indian J Palliat Care. 2018; 24(Suppl 1): S10–S14.
  13. Franchi S, Moschetti G, Amodeo G, et al. Do All Opioid Drugs Share the Same Immunomodulatory Properties? A Review From Animal and Human Studies. Front Immunol. 2019; 10: 2914.
  14. Sande TA, Laird BJA, Fallon MT. The Management of Opioid-Induced Nausea and Vomiting in Patients with Cancer: A Systematic Review. J Palliat Med. 2019; 22(1): 90–97.
  15. Mancini IL, Hanson J, Neumann CM, et al. Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study. J Palliat Med. 2000; 3(1): 49–56.
  16. Daeninck PJ, Bruera E. Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases. J Pain Symptom Manage. 1999; 18(4): 303–309.
  17. Moulin D, Boulanger A, Clark AJ, et al. Canadian Pain Society. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag. 2014; 19(6): 328–335.
  18. Mercadante S, Prestia G, Adile C, et al. Changes of QTc interval after opioid switching to oral methadone. Support Care Cancer. 2013; 21(12): 3421–3424.
  19. Flory JH, Wiesenthal AC, Thaler HT, et al. Methadone Use and the Risk of Hypoglycemia for Inpatients With Cancer Pain. J Pain Symptom Manage. 2016; 51(1): 79–87.e1.
  20. Ikegaki J, Kizawa Y. Delirium Prolonged for Three Days after Addition of One Dose of 5 mg Methadone to Ongoing Opioid. J Palliat Med. 2020; 23(2): 164.
  21. Moksnes K, Dale O, Rosland JH, et al. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial. Eur J Cancer. 2011; 47(16): 2463–2470.
  22. Ripamonti C, Groff L, Brunelli C, et al. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? Journal of Clinical Oncology. 1998; 16(10): 3216–3221.
  23. Nicholson AB, Watson GR, Derry S, et al. Methadone for cancer pain. Cochrane Database Syst Rev. 2017; 2: CD003971.
  24. Chalker C, O'Neill H, Cranfield F. Efficacy of low-dose and/or adjuvant methadone in palliative medicine. BMJ Support Palliat Care. 2019 [Epub ahead of print].

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Medycyna Paliatywna w Praktyce dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl